Alexandre Cinq-Mars

Alexandre Cinq-Mars

Auto-generated profile, based on publicly available information

Alexandre Cinq-Mars


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
ACAlexandre Cinq-Mars
Alexandre Cinq-Mars
PVPierre Voisine
Pierre Voisine
FDFrançois Dagenais
François Dagenais
ÉCÉric Charbonneau
Éric Charbonneau
FJFrédéric Jacques
Frédéric Jacques
MSMario Senechal
Mario Senechal

1 June 2015 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
ACAlexandre Cinq-Mars
Alexandre Cinq-Mars
SVSimon-Pierre Veilleux
Simon-Pierre Veilleux
PVPierre Voisine
Pierre Voisine
FDFrançois Dagenais
François Dagenais
KOKim O'COnnor
Kim O'COnnor
MSMario Senechal
Mario Senechal

1 January 2022 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
ACAlexandre Cinq-Mars
Alexandre Cinq-Mars
MMMontse Massot
Montse Massot
DBDavid Belzile
David Belzile
PTPierre Yves Turgeon
Pierre Yves Turgeon
SDSacha-Michelle Dubois-Sénéchal
Sacha-Michelle Dubois-Sénéchal
MSMario Senechal
Mario Senechal

1 February 2020 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
DBDavid Belzile
David Belzile
ACAlexandre Cinq-Mars
Alexandre Cinq-Mars
MBMathieu Bernier
Mathieu Bernier
MLMarie-Hélène Leblanc
Marie-Hélène Leblanc
CBChristine Bourgault
Christine Bourgault
MSMario Senechal
Mario Senechal

30 July 2025 in JACC: Case Reports
Verified
Journal Article
Open access
ACAlexandre Cinq-Mars
Alexandre Cinq-Mars
FSFiorella Salerno
Fiorella Salerno
CSChristian Steinberg
Christian Steinberg
JGJérôme Garot
Jérôme Garot
SDSuzanne Duhamel
Suzanne Duhamel
LFLaurent Fiorina
Laurent Fiorina
A subcutaneous implantable cardioverter defibrillator (S-ICD) is a validated alternative to a transvenous ICD for patients without pacing indications. However, limited data exist regarding its safety and efficacy in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). A 21-year-old man was referred after a syncope during a sport event. A 12-lead electrocardiogram showed repolarization abnormalities, and cardiac magnetic resonance demonstrated right ventricular dilatation, biventricular dysfunction, and fibrosis compatible with a diagnosis of ARVC. An S-ICD was implanted after successful preimplant screening. Genetic testing identified a known pathogenic plakophilin-2 variant. The patient received an S-ICD. At 18 months, lead noise, undersensing, and oversensing occurred because of reduced QRS amplitude. Imaging confirmed disease progression. The S-ICD was explanted and replaced by a transvenous ICD. The patient was referred for heart transplant evaluation. Our case represents a phenotype variant of ARVC with failure of the S-ICD system due to a temporal change in QRS amplitude over a short period of time. Advanced discrimination algorithms on the S-ICD may not be sufficient to prevent device failure. Cardiac magnetic resonance and genetic testing could eventually play a major role in the selection of a device in patients with ARVC. This case illustrates S-ICD failure associated with rapidly progressive ARVC, underscoring the need for close follow-up and tailored device selection in this population.

14 January 2016 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
MSMario Senechal
Mario Senechal
PBPierre-Louis Bernard
Pierre-Louis Bernard
SCStéphanie Cloutier
Stéphanie Cloutier
MLMarie-Hélène Leblanc
Marie-Hélène Leblanc
ÉLÉric Larose
Éric Larose
MDMichelle Dubois
Michelle Dubois